AbbVie · 12 hours ago
Associate Scientist I, Molecular Biology Core
AbbVie is a company dedicated to discovering and delivering innovative medicines and solutions for serious health issues. They are seeking a motivated Associate Scientist I to design and clone constructs for RNA production, optimize plasmid production workflows, and support both internal and external plasmid production efforts.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Support Plasmid production workflows
Support optimization of E. Coli growth for plasmid production
Support development of new cloning strategies and maximizing cloning efficiency
Assist in the design and molecular cloning of DNA constructs for mRNA production
Conduct laboratory experiments and analysis of results
Participate in team meetings and communication of results
Maintain adherence to rigorous laboratory standards, encompassing meticulous documentation in an online laboratory notebook system and stringent personal safety measures
Qualification
Required
Minimum bachelor's degree in molecular biology, biology, genetics, biochemistry, chemistry, biotechnology, or related discipline
Proficiency in molecular biology techniques related to cloning and plasmid production in E. coli
Strong communication and organizational skills
Motivated to learn and ask questions
Preferred
2+ years of industry experience will be strongly preferred
Experience with mRNA production is preferred
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-09
2026-01-08
Morningstar.com
2026-01-08
Company data provided by crunchbase